跳至主要内容
临床试验/JPRN-jRCT2071230096
JPRN-jRCT2071230096招募中1 期

A Single-Administration Clinical Study to Evaluate the Pharmacokinetics of Bomedemstat (MK-3543) in Healthy Japanese Participants

Tanaka Yoshiyuki0 个研究点目标入组 45 人开始时间: 2023年11月25日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 64age old(—)
性别
All

入选标准

  • 1) Be in good health based on medical history, physical examination, vital sign measurements, 12-lead ECGs at the Screening Visit and before administration of the dose of the study intervention.
  • 2) BMI >= 18.5 and <= 32.0 kg/m2, inclusive, with a body weight >= 50 and <= 100 kg.
  • 3) Is an individual of any sex/gender, from 18 years to 64 years of age inclusive, at the time of providing the informed consent.

排除标准

  • 1) History of clinically significant endocrine, GI, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.
  • 2) History of cancer (malignancy).

研究者

发起方
Tanaka Yoshiyuki

相似试验